What We're Reading: Page 91
Industry reads hand-picked by our editors
Sep 01, 2023
Aug 31, 2023
-
The New York Times
Biden Makes Lower Drug Prices a Centerpiece of His 2024 Campaign
-
The Washington Post
In the Gulf, a growing scramble for Ozempic and other weight-loss drugs
-
Reuters
Blood test for Parkinson’s disease promising in early study
-
Bloomberg
Covid Isn’t Seasonal. So Why Are Covid Booster Shots?
Aug 30, 2023
-
BioCentury
Where is the sweet spot for M&A?
-
Politico
Biden’s NIH pick gives Elizabeth Warren a major concession
-
The Atlantic
How Bad Could BA.2.86 Get?
Aug 29, 2023
Aug 28, 2023
-
CNBC
ADHD drug market faces back-to-school supply strain
-
The New York Times
New RSV Vaccines Aren’t Covered by Some Health Insurance Plans
-
The Wall Street Journal
Cancer Runs in Families. Too Few Are Getting Tested.
-
Politico
The Real Reason Drugs Cost So Much — and Do Too Little
Aug 25, 2023
Aug 24, 2023
-
The Wall Street Journal
Mallinckrodt Lenders to Take Control in Bankruptcy That Cuts $1 Billion in Opioid Payments
-
Fierce Biotech
J&J ends R&D at Janssen’s infectious disease and vaccine unit
-
Bloomberg
Dogs Have a Lyme Disease Vaccine. Now Pfizer Is Making One for People
-
Stat
Vivek Ramaswamy made waves in the debate, much as in biotech
Previous
